Project Details
Description
A Randomized, Open-label, Phase 3 Trial of A+AVD Versus ABVD as Frontline Therapy in Patients With Advanced Classical Hodgkin Lymphoma
| Status | Active |
|---|---|
| Effective start/end date | 12/1/12 → 3/28/30 |
Funding
- MILLENNIUM PHARMACEUTICALS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.